12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Other News

Silence Therapeutics ophthalmic news

Silence completed the consolidation of its corporate activities by reducing headcount at its Berlin, Germany, facility by 5 (16%) to 27 and by closing its U.S. operations in Redwood City, Calif. The company also reduced the number of non-executive directors to...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >